View in EDS

Boosting SIV-specific CD8+ T cell responses prior to ART interruption extends time to SIVmac239 rebound.

Saved in:
Bibliographic Details
Title: Boosting SIV-specific CD8+ T cell responses prior to ART interruption extends time to SIVmac239 rebound.
Authors: Omange WR; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA., Varco-Merth BD; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA., Fadeyi O; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA., Marenco A; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA., Takata H; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA., Duell DM; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA., Goodwin WD; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA., Armitage P; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA., Fennessey CM; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA., Kose E; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA., Immonen TT; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA., Kosmider E; Fred Hutchinson Cancer Center, Seattle, Washington, USA., Bosche WJ; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA., Fast R; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA., Homick C; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA., Oswald K; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA., Shoemaker R; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA., Bochart R; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA., MacAllister R; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA., Labriola CS; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA., Smedley JV; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA., Axthelm MK; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA., Edlefsen PT; Fred Hutchinson Cancer Center, Seattle, Washington, USA., Keele BF; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA., Lifson JD; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA., Gergen J; CureVac SE, Tübingen, Germany., Petsch B; CureVac SE, Tübingen, Germany., Rauch S; CureVac SE, Tübingen, Germany., Picker LJ; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA., Okoye AA; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.
Source: The Journal of clinical investigation [J Clin Invest] 2026 Jan 29; Vol. 136 (6). Date of Electronic Publication: 2026 Jan 29 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: eCollection Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41609736
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Boosting SIV-specific CD8+ T cell responses prior to ART interruption extends time to SIVmac239 rebound.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Omange+WR%22">Omange WR</searchLink>; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.<br /><searchLink fieldCode="AU" term="%22Varco-Merth+BD%22">Varco-Merth BD</searchLink>; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.<br /><searchLink fieldCode="AU" term="%22Fadeyi+O%22">Fadeyi O</searchLink>; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.<br /><searchLink fieldCode="AU" term="%22Marenco+A%22">Marenco A</searchLink>; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.<br /><searchLink fieldCode="AU" term="%22Takata+H%22">Takata H</searchLink>; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.<br /><searchLink fieldCode="AU" term="%22Duell+DM%22">Duell DM</searchLink>; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.<br /><searchLink fieldCode="AU" term="%22Goodwin+WD%22">Goodwin WD</searchLink>; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.<br /><searchLink fieldCode="AU" term="%22Armitage+P%22">Armitage P</searchLink>; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.<br /><searchLink fieldCode="AU" term="%22Fennessey+CM%22">Fennessey CM</searchLink>; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Kose+E%22">Kose E</searchLink>; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Immonen+TT%22">Immonen TT</searchLink>; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Kosmider+E%22">Kosmider E</searchLink>; Fred Hutchinson Cancer Center, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Bosche+WJ%22">Bosche WJ</searchLink>; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Fast+R%22">Fast R</searchLink>; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Homick+C%22">Homick C</searchLink>; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Oswald+K%22">Oswald K</searchLink>; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Shoemaker+R%22">Shoemaker R</searchLink>; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Bochart+R%22">Bochart R</searchLink>; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.<br /><searchLink fieldCode="AU" term="%22MacAllister+R%22">MacAllister R</searchLink>; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.<br /><searchLink fieldCode="AU" term="%22Labriola+CS%22">Labriola CS</searchLink>; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.<br /><searchLink fieldCode="AU" term="%22Smedley+JV%22">Smedley JV</searchLink>; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.<br /><searchLink fieldCode="AU" term="%22Axthelm+MK%22">Axthelm MK</searchLink>; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.<br /><searchLink fieldCode="AU" term="%22Edlefsen+PT%22">Edlefsen PT</searchLink>; Fred Hutchinson Cancer Center, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Keele+BF%22">Keele BF</searchLink>; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Lifson+JD%22">Lifson JD</searchLink>; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Gergen+J%22">Gergen J</searchLink>; CureVac SE, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Petsch+B%22">Petsch B</searchLink>; CureVac SE, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Rauch+S%22">Rauch S</searchLink>; CureVac SE, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Picker+LJ%22">Picker LJ</searchLink>; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.<br /><searchLink fieldCode="AU" term="%22Okoye+AA%22">Okoye AA</searchLink>; Vaccine and Gene Therapy Institute and.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227802877%22">The Journal of clinical investigation</searchLink> [J Clin Invest] 2026 Jan 29; Vol. 136 (6). <i>Date of Electronic Publication: </i>2026 Jan 29 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+for+Clinical+Investigation%22">American Society for Clinical Investigation </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7802877 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1558-8238 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200219738%22">00219738 </searchLink><i>NLM ISO Abbreviation: </i>J Clin Invest <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41609736
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1172/JCI198294
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Boosting SIV-specific CD8+ T cell responses prior to ART interruption extends time to SIVmac239 rebound.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Omange WR
      – PersonEntity:
          Name:
            NameFull: Varco-Merth BD
      – PersonEntity:
          Name:
            NameFull: Fadeyi O
      – PersonEntity:
          Name:
            NameFull: Marenco A
      – PersonEntity:
          Name:
            NameFull: Takata H
      – PersonEntity:
          Name:
            NameFull: Duell DM
      – PersonEntity:
          Name:
            NameFull: Goodwin WD
      – PersonEntity:
          Name:
            NameFull: Armitage P
      – PersonEntity:
          Name:
            NameFull: Fennessey CM
      – PersonEntity:
          Name:
            NameFull: Kose E
      – PersonEntity:
          Name:
            NameFull: Immonen TT
      – PersonEntity:
          Name:
            NameFull: Kosmider E
      – PersonEntity:
          Name:
            NameFull: Bosche WJ
      – PersonEntity:
          Name:
            NameFull: Fast R
      – PersonEntity:
          Name:
            NameFull: Homick C
      – PersonEntity:
          Name:
            NameFull: Oswald K
      – PersonEntity:
          Name:
            NameFull: Shoemaker R
      – PersonEntity:
          Name:
            NameFull: Bochart R
      – PersonEntity:
          Name:
            NameFull: MacAllister R
      – PersonEntity:
          Name:
            NameFull: Labriola CS
      – PersonEntity:
          Name:
            NameFull: Smedley JV
      – PersonEntity:
          Name:
            NameFull: Axthelm MK
      – PersonEntity:
          Name:
            NameFull: Edlefsen PT
      – PersonEntity:
          Name:
            NameFull: Keele BF
      – PersonEntity:
          Name:
            NameFull: Lifson JD
      – PersonEntity:
          Name:
            NameFull: Gergen J
      – PersonEntity:
          Name:
            NameFull: Petsch B
      – PersonEntity:
          Name:
            NameFull: Rauch S
      – PersonEntity:
          Name:
            NameFull: Picker LJ
      – PersonEntity:
          Name:
            NameFull: Okoye AA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 29
              M: 01
              Text: 2026 Jan 29
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1558-8238
          Numbering:
            – Type: volume
              Value: 136
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: The Journal of clinical investigation
              Type: main
ResultId 1